Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, -22060, Pakistan.
Department of Biochemistry and Biotechnology, The Islamia University of Bahawalpur, Bahawalpur, -63100, Pakistan.
BMC Complement Altern Med. 2018 Feb 20;18(1):68. doi: 10.1186/s12906-018-2138-4.
Zanthoxylum armatum DC is an important medicinal plant of south East Asia, and has been used to treat various ailments in traditional medicine including diabetes. This study investigated the in vitro and in vivo antidiabetic and biochemical effects of extracts of Z. armatum in mice.
The extracts of fruit, bark and leaf from Z. armatum were tested for α-glucosidase inhibition activity. Albino mice of either sex weighing (26-30 g) assigned into groups. Diabetes was induced by IP injection of alloxan monohydrate (150 mg/kg). The extracts (500 mg/kg) and standard (Glibenclamide 10 mg/kg) were administered to mice for 15 days. Serum biochemical parameters were monitored for the period of study.
The leaves and bark extracts showed maximum α-glucosidase inhibition (96.61 ± 2.13 and 93.58 ± 2.31% respectively). The extracts treated and the standard treated groups showed significant decrease in the fasting blood glucose levels compared to diabetic control. The effect was more pronounced in mice treated with leaves extract. In the in vivo studies body weights of diabetic mice treated with Z. armatum extracts and the standard did not reduced to extent as observed in diabetic control and this difference was significant (p < 0.05). There was a significance (p < 0.001) improvement in blood hemoglobin, urea, creatinine, cholesterol, and triglycerides of the extracts treated diabetic mice. The extracts showed hypolipidemic effect by reducing the LDL level. The extracts produced no prominent changes in proteins levels.
It can be concluded that Z. armatum extracts showed excellent antidiabetic potential in vivo and in vitro and could be considered for further appraisal in clinical assessment and drug development.
花椒(Zanthoxylum armatum DC)是东南亚一种重要的药用植物,在传统医学中被用于治疗各种疾病,包括糖尿病。本研究旨在研究花椒的果实、树皮和叶提取物在小鼠体内和体外的抗糖尿病和生化作用。
测试了花椒果实、树皮和叶提取物对α-葡萄糖苷酶的抑制活性。将雌雄两性、体重(26-30g)均一的白化小鼠分组。通过腹腔注射一水合阿脲(150mg/kg)诱导糖尿病。给小鼠灌胃(500mg/kg)提取物和标准品(格列本脲 10mg/kg)15 天。在整个研究期间监测血清生化参数。
叶和树皮提取物对α-葡萄糖苷酶的抑制作用最强(分别为 96.61±2.13%和 93.58±2.31%)。与糖尿病对照组相比,提取物治疗组和标准治疗组的空腹血糖水平显著降低。用叶提取物治疗的效果更为明显。在体内研究中,与糖尿病对照组相比,用花椒提取物和标准治疗的糖尿病小鼠的体重没有明显下降,这一差异具有统计学意义(p<0.05)。提取物治疗的糖尿病小鼠的血红蛋白、尿素、肌酐、胆固醇和甘油三酯水平显著改善(p<0.001)。提取物通过降低 LDL 水平显示出降脂作用。提取物对蛋白质水平没有产生明显变化。
可以得出结论,花椒提取物在体内和体外均表现出良好的抗糖尿病潜力,可以考虑进一步进行临床评估和药物开发。